CD133, but Not CD44, May Serve as a Novel Biomarker for Differential Diagnosis Between Basal Cell Carcinoma and Trichoblastomas
Yalan Bi,1 Xiaohua Shi,2 Dian Chen,1 Yi Zhao1 1Department of Dermatology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, People's Republic of China; 2Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Scien...
Saved in:
Main Authors: | Bi Y (Author), Shi X (Author), Chen D (Author), Zhao Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
by: Borger Darrell R, et al.
Published: (2010) -
Basal cell carcinoma or trichoblastoma? Two cases of nasal nodules difficult to distinguish
by: Zhiqiang Cao, et al.
Published: (2022) -
Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: An immunohistochemical study
by: Pournima Y Godge, et al.
Published: (2011) -
CD44-Targeted Nanocarrier for Cancer Therapy
by: Prashant Kesharwani, et al.
Published: (2022) -
Differential expression of HIF-1α in CD44<sup>+</sup>CD24<sup>-/low </sup>breast ductal carcinomas
by: Soares Fernando A, et al.
Published: (2011)